Welcome to the international HTA database

Showing [23806 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2012	Agency for Healthcare Research and Quality (AHRQ)	Drug therapy for rheumatoid arthritis in adults: an update.
2012	National Institute for Health and Care Excellence (NICE)	Breast reconstruction using lipomodelling after breast cancer treatment. NICE interventional procedures guidance 417
2012	NIHR Health Technology Assessment programme	Botulinum toxin type A for the prophylaxis of headaches in adults with chronic migraine
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Dental treatment to correct dental caries in patients undergoing surgery: a review of clinical evidence on safety
2012	NIHR Horizon Scanning Centre (NIHR HSC)	Tofacitinib for moderate to severe chronic plaque psoriasis – second line
2012	HAYES, Inc.	Orthotic compression bracing for treatment of pectus carinatum
2012	Agency for Healthcare Research and Quality (AHRQ)	Drug therapy for psoriatic arthritis in adults: update of a 2007 report.
2012	New Zealand National Health Committee (NHC)	Catheter ablation for the treatment of atrial fibrillation - technology note
2012	NIHR Health Technology Assessment programme	Erlotinib for the first-line treatment of EGFR-TK mutation positive non-small-cell lung cancer
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Chlorhexidine gluconate (CHG) for suturing in the emergency room and perineal washing during vaginal deliveries: a review of safety, evidence-based guidelines and recommendations
2012	NIHR Horizon Scanning Centre (NIHR HSC)	ICX-RHY (Vavelta) for recessive dystrophic epidermolysis bullosa –second line
2012	HAYES, Inc.	Percutaneous epidural adhesiolysis for chronic back pain
2012	Agency for Healthcare Research and Quality (AHRQ)	Dietary supplements in adults taking cardiovascular drugs
2012	New Zealand National Health Committee (NHC)	Problem-solving therapy (PST) for people who present to hospital with self-harm - technology note
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Dental x-rays and cancer: a review of the evidence on safety
2012	HAYES, Inc.	Percutaneous needle aponeurotomy for Dupuytren contracture
2012	Agency for Healthcare Research and Quality (AHRQ)	Chronic kidney disease stages 1–3: screening, monitoring, and treatment.
2012	New Zealand National Health Committee (NHC)	Transcatheter Aortic Valve Implantation (TAVI) - briefing report
2012	NIHR Health Technology Assessment programme	Rivaroxaban for the treatment of deep vein thrombosis and secondary prevention of venous thromboembolism
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Composite resin and amalgam dental filling materials: a review of safety, clinical effectiveness and cost-effectiveness
2012	HAYES, Inc.	Pipeline embolization device (Covidien ev3) for treatment of intracranial aneurysms
2012	NIHR Health Technology Assessment programme	Ruxolitinib for the treatment of myelofibrosis
2012	HAYES, Inc.	Phototherapy for early-stage mycosis fungoides
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Group therapy for adult psychiatric inpatients: a review of clinical evidence and effectiveness
2012	HAYES, Inc.	Plasmapheresis for hypertriglyceridemia-induced pancreatitis
2012	NIHR Health Technology Assessment programme	Eltrombopag for the treatment of chronic immune thrombocytopenic purpura (ITP): a single technology appraisal
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Clopidogrel, prasugrel and ticagrelor in adults with acute coronary syndrome: a review of the clinical effectiveness, cost effectiveness and guidelines
2012	HAYES, Inc.	Provent sleep apnea therapy (Ventus Medical Inc.)
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Neurofeedback and biofeedback for post-traumatic stress disorder, generalized anxiety disorder, and depression: a review of the clinical evidence and guidelines.
2012	HAYES, Inc.	P-Stim (Biegler GmbH) auricular electroacupuncture for pain management
2012	National Evidence-based Healthcare Collaborating Agency (NECA)	[Management and improvement in cancer pain: focusing on narcotic analgesics]
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Negative pressure wound therapy for patients with diabetic foot ulcers and pressure ulcers: a review of the clinical effectiveness
2012	National Evidence-based Healthcare Collaborating Agency (NECA)	[Comparative effectiveness study of catheter ablation for atrial fibrillation]
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Custom foot orthotics for adults with foot conditions: a review of the clinical and cost effectiveness
2012	National Evidence-based Healthcare Collaborating Agency (NECA)	[Clinically relevant venous thromboembolism following hip and knee arthroplasty]
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Routine dental care programs in long term care: a review of the clinical effectiveness and guidelines
2012	National Evidence-based Healthcare Collaborating Agency (NECA)	[Costing methods in healthcare]
2012	Norwegian Knowledge Centre for the Health Services (NOKC)	[Prevention of allergy among children]
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Hydroxocobalamin for cyanide poisoning in the pre-hospital setting: a review of the comparative clinical effectiveness and safety
2012	Agencia de Evaluacion de Tecnologias Sanitarias (AETS)	[1st Expert Panel on viper venomous bite in Spain]
2012	National Evidence-based Healthcare Collaborating Agency (NECA)	[Research on medical care utilization of stroke patients and related factors in Korea]
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Denosumab and zoledronic acid for patients with postmenopausal osteoporosis: a review of the clinical effectiveness, safety, cost effectiveness, and guidelines
2012	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Impact of day care centres in monitoring patients with Obstructive Sleep Apnea Syndrome (OSAS)]
2012	Agencia de Evaluacion de Tecnologias Sanitarias (AETS)	[Economic evaluation of the introduction of the HPV vaccine in Spain to prevent cervical cancer]
2012	National Evidence-based Healthcare Collaborating Agency (NECA)	[A study on Korean adolescents' risk factors of suicide]
2012	NIHR Health Technology Assessment programme	Bevacizumab in combination with capecitabine for the first-line treatment of metastatic breast cancer
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Telemetry devices to monitor cardiac patients: a review of the safety and guidelines
2012	Health Information and Quality Authority (HIQA)	Health technology assessment of a national deep brain stimulation service in Ireland
2012	HAYES, Inc.	Pulmonary thromboendarterectomy for treatment of pulmonary hypertension
2012	National Evidence-based Healthcare Collaborating Agency (NECA)	[Risk factors at the regional level for suicide in the Korean elderly]
2012	Agency for Healthcare Research and Quality (AHRQ)	Noninvasive technologies for the diagnosis of coronary artery disease in women
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Cannabinoids for the treatment of post-traumatic stress disorder: a review of the clinical effectiveness and guidelines
2012	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	[HIV screening in the general population]
2012	HAYES, Inc.	Qsymia (phentermine/topiramate; Vivus Inc.) for obesity management
2012	National Evidence-based Healthcare Collaborating Agency (NECA)	Asian study on the value for a QALY: Korean results
2012	Norwegian Knowledge Centre for the Health Services (NOKC)	[The effectiveness of health promotion and preventive interventions on nutrition, physical activity, obesity, and sexual health in children and adolescents]
2012	HAYES, Inc.	Stereotaxis niobe magnetic navigation system (Stereotaxis Inc.) for percutaneous coronary intervention in coronary artery disease
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Infliximab versus methotrexate, etanercept, adalimumab, and ustekinumab for plaque psoriasis: a review of the comparative clinical efficacy, safety and cost effectiveness
2012	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Screening for colorectal cancer part 1: screening-tests and program design
2012	HAYES, Inc.	Relieva balloon sinuplasty (Acclarent Inc.) for chronic sinusitis in adults
2012	National Evidence-based Healthcare Collaborating Agency (NECA)	[Diagnostic accuracy of anti-CCP antibody test in rheumatoid arthritis: systematic review]
2012	Norwegian Knowledge Centre for the Health Services (NOKC)	[List size and quality of care among GPs within The Regular General Practitioner Scheme]
2012	Medical Services Advisory Committee (MSAC)	Testing for HER-2 status in advanced or metastatic breast cancer (stage IIIA-IV) to access lapatinib
2012	Agency for Healthcare Research and Quality (AHRQ)	Registry of patient registries (RoPR): policies and procedures
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Sterile pre-filled saline syringes for acute care patients: a review of clinical evidence, cost-effectiveness, evidence-based guidelines, and safety
2012	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Lenalidomide (Revlimid®) for the first-line therapy of transplant-ineligible patients with multiple myeloma
2012	HAYES, Inc.	Relieva balloon sinuplasty (Acclarent Inc.) for chronic sinusitis in children
2012	National Evidence-based Healthcare Collaborating Agency (NECA)	[Polysomnography in the diagnosis of sleep-related breathing disorders]
2012	Norwegian Knowledge Centre for the Health Services (NOKC)	[Effects of organisational interventions for mental health services]
2012	Agency for Healthcare Research and Quality (AHRQ)	Treatment for glaucoma: comparative effectiveness
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Modafinil for sleep disorders and fatigue secondary to multiple sclerosis: a review of the clinical efficacy and safety
2012	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	[Evidence overview of therapeutic hypothermia]
2012	HAYES, Inc.	Sacroiliac joint fusion for the treatment of adult low back pain
2012	National Evidence-based Healthcare Collaborating Agency (NECA)	[Efficacy of atomoxetine and methylphenidate in attention deficits hyperactivity disorder in adults: a rapid review]
2012	Norwegian Knowledge Centre for the Health Services (NOKC)	[Effects of organised follow-up of behaviour that may increase risk of disease in adults]
2012	Danish Centre for Evaluation and Health Technology Assessment (DACEHTA)	[Examination and treatment of older people after a fall – a health technology assessment]
2012	Medical Services Advisory Committee (MSAC)	Holmium Laser Enucleation of the Prostate (HOLEP) combined with tissue morcellation
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Subcutaneous immunotherapy for the treatment of allergies: a review of the clinical efficacy, safety and guidelines
2012	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Researchers' perceptions about the clinical and health services research call]
2012	HAYES, Inc.	Selenia dimensions digital tomosynthesis system (Hologic Inc.) for diagnostic mammography
2012	National Evidence-based Healthcare Collaborating Agency (NECA)	[A systematic review of the diagnostic accuracy of FDG PET/PET-CT for fever of unknown origin]
2012	Norwegian Knowledge Centre for the Health Services (NOKC)	[Effects of support and follow-up interventions for people with severe mental illness]
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Electrocardiograms versus x-rays for guided placement of central venous catheter tips: a review of clinical and cost-effectiveness
2012	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Catalan arthroplasty register. 2nd report (data 2005-2010)]
2012	HAYES, Inc.	Seprafilm adhesion barrier (Genzyme Corp.) for prevention of abdominal adhesions after general abdominal surgery
2012	Norwegian Knowledge Centre for the Health Services (NOKC)	[The effectiveness of primary interventions to prevent the use of tobacco, alcohol and other drugs among children and adolescents]
2012	Agency for Healthcare Research and Quality (AHRQ)	Management of asymptomatic carotid stenosis
2012	HAYES, Inc.	Xoft Axxent eBx electronic brachytherapy system (iCAD Inc.) for early-stage breast cancer
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Sodium chloride inhalation for the treatment of cystic fibrosis: a review of the clinical evidence, cost-effectiveness and guidelines
2012	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Pharmacological treatment for controlled ovarian hyperstimulation in vitro fertilization]
2012	HAYES, Inc.	Seprafilm adhesion barrier (Genzyme Corp.) for prevention of abdominal adhesions after gynecologic surgery
2012	HAYES, Inc.	Accelerated partial breast irradiation for breast cancer using conformal and intensity-modulated radiation therapy
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Drug eluting stents in adults with acute coronary syndrome: a review of the clinical effectiveness, safety and guidelines
2012	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Non-traumatic neck pain: appropriateness use of diagnostic imaging tests]
2012	HAYES, Inc.	SNaP wound care system (Spiracur Inc.) for treatment of lower extremity ulcers
2012	HAYES, Inc.	Antibiotic-coated sutures
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Non-alcohol hand sanitizers for non-healthcare personnel: a review of the clinical effectiveness and guidelines
2012	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Idebenone for the treatment of Friedreich's ataxia]
2012	HAYES, Inc.	Solesta (Q-Med AB) for treatment of fecal incontinence
2012	Agency for Healthcare Research and Quality (AHRQ)	The impact of pre-transplant red blood cell transfusions in renal allograph rejection